Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches joint with Stromal Cells in Immunity and Disease Scientific Organizers: Shannon J. Turley and Thomas A. Wynn Date: February 19 - 23, 2020
Location: Fairmont Empress Victoria, Victoria, BC, Canada Fibrosis or scarring leads to destruction of organ architecture with loss of function and is an important cause of morbidity and mortality worldwide. Fibrosis affects nearly all tissues and organ systems and is a major pathogenic feature of many chronic inflammatory diseases including interstitial lung disease, nonalcoholic steatohepatitis (NASH), glomerulonephritis, heart disease, Crohn’s disease, and systemic sclerosis. Fibrotic tissue remodeling also influences cancer metastasis and cancer therapy. Recent advances have provided a deeper understanding of the pathogenesis of fibrosis and have revealed novel drug targets that are at various stages of clinical development. This conference is the 7th Keystone Symposium on Fibrosis, which was established in 2007 and is intended to be the premier international meeting for anyone with an interest in fibrosis. The conference brings together researchers from a broad range of interests including epithelial biology, vascular biology, cancer, stem and tissue progenitor cell biology, tissue repair and regeneration, as well as those with disease-specific interests. Finally, this conference is being paired with another Keystone Symposia conference on Stromal Cells in Immunity and Disease. Hosting these two conferences together will bring together academic, clinical, and translational researchers to discuss core mechanisms driving inflammation and fibrosis, and to compare and contrast fibrotic diseases of different organs, discuss the best preclinical models, and debate emerging therapies. Scholarship Deadline: October 17 2019 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.
IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for short talks. Abstracts may be submitted for poster presentations up to 6 weeks prior to meeting start date based on availability
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Genentech, Inc.
Pfizer Inc.
|